These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8977589)

  • 21. Hormone treatment of breast cancer.
    Segaloff A
    JAMA; 1975 Dec; 234(11):1175-7. PubMed ID: 1242442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of advanced breast cancer with formestane.
    Murray R; Pitt P
    Ann Oncol; 1994; 5 Suppl 7():S11-3. PubMed ID: 7873455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of adjuvant endocrine therapy for breast cancer.
    Ingle JN
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4392s-4396s; discussion 4411s-4412s. PubMed ID: 11916230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrine treatment of gynecologic carcinomas].
    Maass H
    Fortschr Med; 1975 Oct; 93(28):1313-5. PubMed ID: 58826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Simultaneous hormonal and drug therapy, compared to hormonal therapy, followed by chemotherapy, in the treatment of metastasizing breast neoplasms. Preliminary results of an ongoing study].
    Cavalli F; Alberto P; Jungi WF; Martz G; Barrelet L; Obrecht JP; Brunner KW
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1964-6. PubMed ID: 749193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
    Rose DP; Davis TE
    Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
    Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer of the breast: the past decade (second of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
    [No Abstract]   [Full Text] [Related]  

  • 33. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
    Labrie F
    J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer.
    Levine RM; Lippman ME
    Cancer Treat Rep; 1984 Apr; 68(4):573-6. PubMed ID: 6370427
    [No Abstract]   [Full Text] [Related]  

  • 35. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.
    Wendt AG; Jones SE; Salmon SE
    Cancer Treat Rep; 1980; 64(2-3):269-73. PubMed ID: 6893293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results and merit of estrogen receptor data derived from metastatic tumors of the breast.
    Jochimsen PR; Ness SJ; Sherman BM
    Surg Gynecol Obstet; 1978 Dec; 147(6):842-4. PubMed ID: 715657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aromatase inhibitors: rationale for use following antiestrogen therapy.
    Yue W; Santen RJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
    Harris AL; Dowsett M; Jeffcoate SL; McKinna JA; Morgan M; Smith IE
    J Clin Endocrinol Metab; 1982 Oct; 55(4):718-22. PubMed ID: 6213633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.